We clarified nitric oxide (NO) production in the rat uterus by electron paramagnetic resonance spectroscopy and with Fe-N-(dithiocarboxy) sarcosine complex (an NO-trapping reagent). We examined changes in NO production in the whole uterus, decidua, and myometrium (gestational days 13.5-21.5). The expression of nitric oxide synthase (NOS) isoforms was also examined by quantitative reverse transcription-polymerase chain reaction. The uterine NO levels were low on day 13.5, peaked on day 17.5, and thereafter decreased significantly. The NO production levels in the decidua and myometrium were the same on day 13.5, but the levels in the decidua were 2-to 4-fold higher than those in the myometrium from day 15.5 onwards. The NOS-2 mRNA expression pattern correlated well with changes in the NO levels in the decidua, whereas the NOS-3 mRNA was expressed constantly during gestation. Thus NOS-2-generated NO in the decidua contributed significantly to uterine NO levels.
Nitric oxide (NO) has come to be recognized as an important mediator of multiple cellular functions. During pregnancy plasma and urinary nitrate levels, which might reflect NO levels, are elevated in humans and rats. 1) Moreover, increased nitric oxide synthase (NOS) activity is observed in several tissues of guinea pigs. 2) Elevated levels of circulating nitrates are likely to be a consequence of increased NO production in maternal peripheral tissues and/or placenta.
3) Upregulation of NO synthesis in the rat myometrium has also been reported. 4) Increased NO production in the rat uterus during pregnancy is a result of increased expression of NOS-2, 5, 6) but the NO metabolites were measured in terms of the NO production in the supernatant obtained from uterine tissue cultures during a 24-h period. 6) Hence crucial data on the time course of NO production in the uterus is not available, although it has been proposed that NO plays a decisive role in the maintenance of normal pregnancy. 7) During pregnancy the endometrium proliferates and forms the decidua, which is responsible for fetal-maternal interaction. These processes have been reported to be related to the role of NO, 8) but the contributions of the decidua and myometrium to uterine NO production have not been reported.
To clarify the physiological role of NO, it would be useful to have knowledge of the in vivo levels and distribution of NO in specific tissues, but this is difficult because endogenously generated NO is a very shortlived gaseous free radical. 9, 10) Furthermore, NO reacts with many substances, including molecular oxygen and super oxide, to generate NO derivatives such as nitrogen dioxide, peroxynitrite, and nitrate. 11) To circumvent these problems, combination of an NO-trapping technique that involves the use of the Fe-N-(dithiocarboxy) sarcosine (Fe-DTCS) complex and electron paramagnetic resonance (EPR) spectroscopy has successfully been used to detect NO levels in biological systems. 12, 13) In the present study, in order to determine the NO production in the rat uterus during gestation, we measured NO production by trapping NO in the uterus and then did EPR analysis; we also examined the expression levels of NOS-2 and -3, which are responsible for NO production in the decidua and myometrium.
Materials and Methods
Animals and treatments. Female Crj:Wistar rats (Charles River Japan, Yokohama, Japan), aged 10-12 weeks at the time of mating, were used. They were maintained on a commercial diet (CE-2; CLEA Japan, Tokyo) and tap water ad libitum. The conditions were as follows: temperature, 22 C AE 3 C; relative humidity, 55% AE 10%; and a constant 12L:12D schedule. Three females were placed with a male overnight, and the presence of sperm was detected the next morning by means of a vaginal smear. Noon of the day on which sperm was detected was designated day 0.5 of gestation, and the females were maintained individually thereafter. All procedures were performed under the guidance of the Committee for Animal Experimentation of Azabu University (assurance no. #050203-1).
EPR spectroscopy. NO production in the pregnant rats was monitored from day 13.5 to 21.5 by the NO-trapping technique, followed by EPR analysis. To trap NO in the uterus, the Fe-DTCS complex was dissolved in phosphate-buffered saline and injected subcutaneously at a dose of 500 mg/kg of body weight for 0.5 h before sampling. The rats were decapitated under ether anesthesia. Blood was quickly collected from the abdominal vein; the whole uterus was then removed and divided into two sections: the decidua and the y To whom correspondence should be addressed. Fax: +81-42-769-1696; E-mail: takizawa@azabu-u.ac.jp Abbreviations: EPR, electron paramagnetic resonance; Fe-DTCS, Fe-N-(dithiocarboxy) sarcosine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; L-NAME, N G -nitro-L-arginine-methyl ester; NO, nitric oxide; NOS, nitric oxide synthase; RT-PCR, reverse transcription-polymerase chain reaction myometrium. Each sample (approximately 0.5 g) was minced with surgical scissors, transferred to a quartz EPR tube, and frozen immediately in liquid nitrogen. To verify that the EPR spectrum resulted from the activity of uterine NOS, an NOS-specific inhibitor, N G -nitro-L-arginine-methyl ester (L-NAME; Wako Pure Chemical Industries, Osaka, Japan), was administered subcutaneously to the pregnant rats on gestational day 17.5 at a dose of 100 mg/kg of body weight 1 h before sampling.
EPR spectra were recorded with an EPR spectrometer (JES-TE3X; JEOL, Tokyo) under the following conditions: microwave frequency ¼ 9131.60-9100.30 MHz, microwave power ¼ 10 mW; magnetic field center 320.0 mT; magnetic width þ=À ¼ 10.00 mT, modulation frequency ¼ 100.00 kHz/width ¼ 0.32 mT; time constant ¼ 0.3 s, sweep time ¼ 4.0 min, amplitude 40-100. We used transparent glass Dewar vessel attached an EPR spectrometer to record EPR spectroscopy at À196
C. The marker in the internal standard method for the cavity was manganese oxide (MnO) inserted in the cavity to determine the relative intensity of the ESR signals in the opposite phase. Taking into consideration the fact that the signal height of the NO-Fe-DTCS complex can be used as an index of NO formation, 13) the heights of the NO-Fe-DTCS and MnO signals were measured simultaneously, and the ratio of the signal heights was used to quantify NO production. The g value (spectroscopic splitting constant) was calculated from the resonance frequency of the signal and the value of the magnetic field as an internal standard of MnO.
Analysis of the expression of the Nos-2 and Nos-3 genes by reverse transcription-polymerase chain reaction. Total RNA was extracted from the decidua and myometrium of the rats from gestational day 13.5 to day 21.5 using an RNA extraction kit (Isogen; NPG, Toyama, Japan), following the manufacturer's instructions. First-strand cDNA was synthesized from total RNA (1 mg) using reverse transcriptase (RT; SuperScript III; Gibco BBL, Tokyo) and an oligo d(T) 12 primer. PCR amplification of the reverse-transcribed cDNA was done with primers specifically designed for Nos-2 (forward: 5 0 -TTCACGA-CACCCTTCACCACAA-3 0 and reverse: 5 0 -CCATCCTCCTGCCCA-CTTCCTC-3 0 , 912 bp) and for Nos-3 (forward: 5 0 -TGGGCAGCAT-CACCTACGA-3 0 and reverse: 5 0 -TCCCGAGCATCAAATCCT-3 0 , 373 bp). These primers were designed on the basis of the rat Nos-2 (accession no. D14051) and Nos-3 (accession no. AF085195) genes. The glyceraldehyde-3-phosphate dehydrogenase gene (Gapdh) was used as an internal control to normalize template concentrations. Quantitative determination of the expression of the NOSs was as described previously. 14) Briefly, for PCR, 1 ml of reverse-transcribed cDNA was added to a 20-ml reaction mixture containing 250 mM of each of the deoxyribonucleotide triphosphates (dNTPs); next 1 unit of Taq polymerase (rTaq; Takara, Kyoto, Japan) and 0.2 mM of each primer were added. Thermal cycling was under the following conditions: 20 cycles for Gapdh and 30 cycles for Nos-2 and Nos-3 at 94 C for 1 min, at 62 C for Nos-2 and 60 C for Gapdh, and Nos-3 for 1 min, and at 72 C for 1 min (GeneAmp 2400; Perkin Elmer Japan, Yokohama, Japan). Due to the above cycle profiles for the genes, the resulting PCR product concentration was proportional to the starting cDNA concentration. The PCR products were separated on a 1.5% agarose gel and stained with SYBR Green I (Takara, Kyoto, Japan). Quantitative analysis of the expression levels of rat NOS-2 and -3 was performed by scanning the gels, stained with SYBR Green I, with a Fluoro-Image Analyzer (FLA-2000; Fujifilm, Tokyo). The images were analyzed with MacBas image software (MacBas version 2.5, Fujifilm).
Statistical analysis. Data were expressed as the mean AE standard error mean (SEM). The differences among the groups of rats were assessed by analysis of variance (ANOVA) or by Student's t test. When the difference among the groups was found to be significant, Scheffe's test was used to determine which groups were different. p values of less than 0.05 were considered to be statistically significant.
Results and Discussion
The EPR spectra of the standard samples of the NOFe-DTCS complex in fresh blood revealed a typical triplet signal (g ¼ 2:038), previously identified as NOFe-DTCS by Yoshimura 12) (Fig. 1A) . We identified the g ? signal of the Cu-dithiocarbamate complex 13) in the EPR spectrum of Fe-DTCS trapped in the whole uterus of rats pretreated with L-NAME (100 mg/kg of body weight) (Fig. 1B) ; the NO-Fe-DTCS signal almost disappeared after L-NAME treatment. The NO-Fe-DTCS signal was superimposed on the g ? signal of the Cu-dithiocarbamate complex 13) in the EPR spectrum derived from the whole uterus of rats on gestational day 17.5 ( Fig. 1C) , consistently with the findings of previous studies. 14, 15) These findings provide strong evidence that the EPR spectra observed in the present study were derived from endogenous NO in the uterus.
The NO-Fe-DTCS and MnO signal heights were measured simultaneously, and the ratio of these heights was used to quantify NO production (Fig. 2) . The changes in this ratio in the whole uterus, decidua, and myometrium of rats from gestational day 13.5 to 21.5 were determined. As revealed by EPR analysis, NO was detected in the uterus throughout gestation. The NO levels in the whole uterus were significantly higher (by 3.2-fold) on day 17.5 than on day 13.5, and the levels were significantly low on day 19.5 ( Fig. 2) . The NO levels in the decidua were the same as those in the myometrium on gestational day 13.5. On the other hand, the levels in the decidua were higher than those in the myometrium from gestational day 15.5 to day 21.5. Moreover, the pattern of NO production in the decidua correlated well with that in the whole uterus (Fig. 2) . NO production in the myometrium showed slight but significant changes during gestation (Fig. 2 ). An analysis of NO production in the uterus during pregnancy has been reported, 6) but in that study, the NO metabolites in the supernatant obtained from uterine tissue cultures A, EPR spectrum of a standard sample of the NO-Fe-DTCS complex in fresh blood. B, EPR spectrum of Fe-DTCS trapped in the whole uterus after administration of L-NAME (100 mg/kg of body weight) on day 17.5 of gestation. C, EPR spectrum of the NO-Fe-DTCS complex detected in the uterus on day 17.5 of gestation. The heights of the NO-Fe-DTCS (a) and MnO (b) signals were measured simultaneously. The ratio of the signal heights (a/b) was used to quantify NO production.
were measured during a 24-h period. The findings are therefore somewhat vague, and it is difficult to clarify the crucial time course of NO production in the tissues. In contrast, the results reported here are based on a more direct method of determining NO levels in the uterus. This is the first report on the developmental time course of NO production in the rat uterus during pregnancy.
To examine the expression of the NOS isoforms responsible for NO production in the rat decidua and myometrium, quantitative RT-PCR analysis was performed using the total RNA extracted from these tissues. NOS-2 mRNA expression in the decidua was significantly higher on day 17.5 than on day 13.5 or 15.5. Moreover, NOS-2 mRNA levels in the decidua decreased during the later stages and the levels were significantly lower on day 19.5 than on day 17.5 ( Fig. 3A) . This pattern of NOS-2 mRNA expression was similar to the pattern of NO production in the decidua, as revealed EPR spectra of the whole uterus ( ), decidua ( ), and myometrium ( ) were recorded from gestational day 13.5 to day 21.5. Data are expressed as the mean AE SEM for five individual experiments. Data that differ significantly (p < 0:05) are indicated by letters at the tops of the bars. The asterisks at the tops of the bars indicate significant differences between the levels in the decidua and the myometrium at the same stage of pregnancy.
A C B D Fig. 3 . Changes in NOS-2 and -3 mRNA Levels in the Uterus during Gestation. A, C, Changes in NOS-2 and -3 mRNA levels in the uterus, decidua (A), and myometrium (C) from gestational day 13.5 to day 21.5. The relative levels were calculated as percentages relative to the levels of an appropriate control gene, Gapdh. Data are expressed as the mean AE SEM for five individual experiments. Data that differ significantly (p < 0:05) are indicated by letters at the tops of the bars. B, D, Separation of the RT-PCR products amplified from total RNA extracted from the decidua (B) and the myometrium (D) on 1.5% agarose gel. The expected product sizes were 983 bp for Gapdh, 912 bp for Nos-2, and 373 bp for Nos-3. M, DNA size markers.
by EPR analysis (Fig. 2) . In contrast, the decidual NOS-3 mRNA and myometrial NOS-2 and -3 mRNA levels did not change remarkably during gestation (Fig. 3A,  C) . Taking into consideration that the NO production capability of NOS-2 is high while that of NOS-3 is low, 7) the present findings suggest that NO production in the decidua, in particular the peak NO production on gestational day 17.5, is catalyzed predominantly by NOS-2. Moreover, the results of this study provide a basis for further research on the regulatory mechanisms underlying the changes in the expression, particularly that of NOS-2, and the function of NO in the uterus.
It has been reported that high levels of NO production in the myometrium during mid-gestation play a role in maintaining pregnancy by inhibiting uterine smooth muscle constriction, 16, 17) and the findings of present study correlate well with these reports. In addition, the present study indicates that the decidua is a major region of uterine NO production. It is difficult to conclude that the large quantities of NO produced in the decidua are capable of relaxing the uterine smooth muscles, because NO is known to be a very short-lived gaseous free radical. 10, 11) Hence we speculate that the NO produced in the decidua plays a different role. In NOS-2 À=À mice, the decidua had reduced cellularity and the decidual arteries had abnormally thickened walls, indicating that NOS-2 had a functional role in the maintenance of decidual cellular integrity and the development of appropriate uterine vasculature. 8) Therefore, the NO generated by NOS-2 in the decidua play a supportive role in promoting embryo survival. Although the rat decidua can be distinguished from the myometrium, previous studies that measured NOS-2 and NOS-3 in the uterus did not clearly distinguish between the decidua and the myometrium. 5, 6) Hence in those studies, the NOS levels in the decidua could not be distinguished from the overall levels in the whole uterus. We regard the time course of the changes in NO and NOS levels in the decidua and myometrium reported here as information that cannot be obtained from readouts of the baseline levels of mixed tissues.
